Research Progress of 18F-FDG PET/CT in Radiotherapy of Non-small Cell Lung Cancer
ZHANG Shilai, PU Weiwei, WEI Hongjiao, XIAO Guoyou
Department of Nuclear Medicine, Guangxi Radiology and Clinical Medicine Research Center, Guangxi Key Clinical Specialty (Medical Imaging), Superiority Cultivation Discipline (Medical Imaging), Guangxi Medical University Affiliated Tumor Hospital, Nanning Guangxi 530021, China
Abstract：Non-small cell lung cancer (NSCLC) is one of the main types of lung cancer. The incidence rate is increasing, most patients cannot be treated by surgery when they were diagnosed. Radiotherapy is one of the main treatment methods for NSCLC patients. How to improve the accuracy of radiotherapy had been a problem that clinicians have been studying. In this paper, based on relevant literature, 18F-fluoro deoxy glucose positron emission tomography is applied to all aspects of NSCLC radiotherapy, which can significantly improve the accuracy of NSCLC diagnosis and the accuracy of target area delineation a comprehensive review to provide a reference for the clinical efficacy and prognosis of patients.
张实来，蒲维维，韦红娇，肖国有. 18F-FDG PET/CT在非小细胞肺癌放射治疗中应用的研究进展[J]. 中国医疗设备, 2020, 35(9): 35-38.
ZHANG Shilai, PU Weiwei, WEI Hongjiao, XIAO Guoyou. Research Progress of 18F-FDG PET/CT in Radiotherapy of Non-small Cell Lung Cancer. China Medical Devices, 2020, 35(9): 35-38.
Allemani C,Matsuda T,Di Carlo V,et al.Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J].Lancet,2018,391:1023-1035.
